Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Los Angeles, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Immix Biopharma, Inc. has filed 239 SEC EDGAR filings since 20 Jul 2021

SEC filing history

Showing 176-200 of 239 matching filings.

Per page
25
Current page
8
4

4 filing

Filing date
18 Jul 2022
Reporting date
14 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Jul 2022
Reporting date
14 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Jul 2022
Reporting date
14 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Jul 2022
Reporting date
14 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Jul 2022
Reporting date
14 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Jul 2022
Reporting date
14 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Jul 2022
Reporting date
14 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Jul 2022
Reporting date
14 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
RW WD File 333-265292

RW WD filing

Filing date
30 Jun 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-265292

FWP filing

Filing date
27 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DRS File 377-06207

DRS filing

Filing date
24 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-41159

10-Q filing

Filing date
13 May 2022
Reporting date
31 Mar 2022
Next action
Verify source filing
DEFA14A File 001-41159

DEFA14A filing

Filing date
25 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-41159

DEF 14A filing

Filing date
25 Apr 2022
Reporting date
25 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-41159

10-K filing

Filing date
28 Mar 2022
Reporting date
31 Dec 2021
Next action
Verify source filing
SC 13G/A File 005-93202

SC 13G/A filing

Filing date
02 Mar 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-93202

AMENDMENT TO SC 13G

Filing date
11 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-93202

SC 13G filing

Filing date
09 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-262336

S-8 filing

Filing date
25 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41159

8-K filing

Filing date
19 Jan 2022
Reporting date
19 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
18 Jan 2022
Reporting date
15 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41159

8-K filing

Filing date
12 Jan 2022
Reporting date
12 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41159

8-K filing

Filing date
03 Jan 2022
Reporting date
03 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .